Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • LMT vs MRNA✓SelectedUSD · MRNALMT vs MRNA performance historyLatest closeAs of-1.11%11/20
Stock and ETF performance explorer

LMT vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+143.5%
MRNA return
+786.4%
Excess return
-642.9%
Maximum drawdown
-36.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.1%-2.2%+1.1%-1.1%
7D-5.1%-12.7%+7.6%-5.2%
30D+2.5%-20.7%+23.2%+2.5%
3M-0.4%+46.3%-46.7%-0.5%
6M+9.6%+305.2%-295.6%+9.1%
YTD+19.0%+561.2%-542.2%+17.8%
1Y+23.9%+772.1%-748.2%+22.4%
3Y+38.0%+147.0%-108.9%+37.1%
5Y+89.3%-26.1%+115.4%+90.1%
All+143.5%+786.4%-642.9%+112.6%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling